Jonathan P. Terdiman, MD

---

Additional Websites

• Physician Referral Directory

---

Education

Princeton University, A.B., cum laude, 1985
Columbia University, College of Physicians and Surgeons, M.D., 1989

---

Professional Experience

• 1989-1992
  Resident in Internal Medicine, University of California, San Francisco, San Francisco CA
• 1992-1993
  Fellow in Critical Care Medicine, University of California, San Francisco, San Francisco, CA
• 1993-1996
  Fellow in Gastroenterology, University of California, San Francisco, San Francisco, CA
• 1996-2000
  Staff Physician, Department of Veterans Affairs Medical Center, San Francisco, CA
• 1996-2002
  Assistant Clinical Professor of Medicine, University of California, San Francisco, San Francisco, CA
• 1996-present
  Staff Physician, University of California, San Francisco Medical Center, San Francisco, CA
• 1996-present
  Director of the Colorectal Cancer Prevention Program, UCSF, San Francisco, CA
• 1998-present
  Clinical Director, Center for Inflammatory Bowel Disease, UCSF, San Francisco, CA
• 1998-present
  Member, Cancer Center, University of California, San Francisco, San Francisco, CA
• 1998-present
  Member, Gastrointestinal Oncology Section, American Gastroenterological Society, Bethesda, MD
• 1999-present
  Member, Colorectal Cancer Initiative Team, American Cancer Society California Division, Oakland, CA
• 2000-present
  Chair, Abstract Review Committee, GI Oncology Section, AGA, Bethesda, MD
• 2001-present
  Co-Chair, Crohn's and Colitis Foundation, northern California Chapter, Medical Advisory Board
• 2002-present
  Associate Professor of Clinical Medicine, University of California, San Francisco, San Francisco, CA
• 2003-present
  Director, Gastroenterology Fellowship, University of California, San Francisco, San Francisco, CA
• 2005-present
  Member, Academy of Medical Educators, University of California, San Francisco, SF, CA

---

Honors & Awards

• 2000
  UCSF Medical School Class of 2002, Excellence in Small Group Instruction, recipient
• 2002
  UCSF Medical School Class of 2004, Excellence in Small Group Instruction, recipient
• 2004
  UCSF Medical School Class of 2006, Excellence in Small Group Instruction, recipient
• 2005
  Excellence in Direct Teaching, recipient, UCSF Academy of Medical Educators

---

Selected Publications

1. Yurgelun MB, Mercado R, Rosenblatt M, Dandapani M, Kohlmann W, Conrad P, Blanco A, Shannon KM, Chung DC, Terdiman J, Gruber SB, Garber JE, Syngal S, Stoffel EM. Impact of genetic testing on endometrial cancer risk-reducing practices in women at risk for Lynch syndrome. Gynecol Oncol. 2012 Dec; 127(3):544-51.
   View on PubMed
2. Kuppermann M, Wang G, Wong S, Blanco A, Conrad P, Nakagawa S, Terdiman J, Ladabaum U. Preferences for outcomes associated with decisions to undergo or forgo genetic testing for Lynch syndrome. Cancer. 2013 Jan 1; 119(1):215-25.
   View on PubMed
3. Katz L, Gisbert JP, Manoogian B, Lin K, Steenholdt C, Mantzaris GJ, Atreja A, Ron Y, Swaminath A, Shah S, Hart A, Lakatos PL, Ellul P, Israeli E, Svendsen MN, van der Woude CJ, Katsanos KH, Yun L, Tsianos EV, Nathan T, Abreu M, Dotan I, Lashner B, Brynskov J, Terdiman JP, Higgins PD, Chaparro M, Ben-Horin S. Doubling the infliximab dose versus halving the infusion intervals in Crohn's disease patients with loss of response. Inflamm Bowel Dis. 2012 Nov; 18(11):2026-33.
   View on PubMed
4. Larsen M, Hills N, Terdiman J. The impact of the quality of colon preparation on follow-up colonoscopy recommendations. Am J Gastroenterol. 2011 Dec; 106(12):2058-62.
   View on PubMed
5. Lin KK, Velayos F, Fisher E, Terdiman JP. Durability of infliximab dose intensification in Crohn's disease. Dig Dis Sci. 2012 Apr; 57(4):1013-9.
   View on PubMed
6. Ladabaum U, Wang G, Terdiman J, Blanco A, Kuppermann M, Boland CR, Ford J, Elkin E, Phillips KA. Strategies to identify the Lynch syndrome among patients with colorectal cancer: a cost-effectiveness analysis. Ann Intern Med. 2011 Jul 19; 155(2):69-79.
   View on PubMed
7. Khan O, Blanco A, Conrad P, Gulden C, Moss TZ, Olopade OI, Kupfer SS, Terdiman J. Performance of Lynch syndrome predictive models in a multi-center US referral population. Am J Gastroenterol. 2011 Oct; 106(10):1822-7; quiz 1828.
   View on PubMed
8. Terdiman JP. The prevention of colitis-related cancer by 5-aminosalicylates: an appealing hypothesis that remains unproven. Am J Gastroenterol. 2011 Apr; 106(4):737-40.
   View on PubMed
9. Day LW, Espey DK, Madden E, Segal M, Terdiman JP. Screening prevalence and incidence of colorectal cancer among American Indian/Alaskan natives in the Indian Health Service. Dig Dis Sci. 2011 Jul; 56(7):2104-13.
   View on PubMed
10. Terdiman JP, McQuaid KR. Surveillance guidelines should be updated to recognize the importance of serrated polyps. Gastroenterology. 2010 Nov; 139(5):1444-7.
    View on PubMed
11. El-Nachef N, Terdiman J, Mahadevan U. Anti-tumor necrosis factor therapy for inflammatory bowel disease in the setting of immunosuppression for solid organ transplantation. Am J Gastroenterol. 2010 May; 105(5):1210-1.
    View on PubMed
12. Stoffel EM, Mercado RC, Kohlmann W, Ford B, Grover S, Conrad P, Blanco A, Shannon KM, Powell M, Chung DC, Terdiman J, Gruber SB, Syngal S. Prevalence and predictors of appropriate colorectal cancer surveillance in Lynch syndrome. Am J Gastroenterol. 2010 Aug; 105(8):1851-60.
    View on PubMed
13. Burt RW, Barthel JS, Dunn KB, David DS, Drelichman E, Ford JM, Giardiello FM, Gruber SB, Halverson AL, Hamilton SR, Ismail MK, Jasperson K, Lazenby AJ, Lynch PM, Martin EW, Mayer RJ, Ness RM, Provenzale D, Rao MS, Shike M, Steinbach G, Terdiman JP, Weinberg D. NCCN clinical practice guidelines in oncology. Colorectal cancer screening. J Natl Compr Canc Netw. 2010 Jan; 8(1):8-61.
    View on PubMed
14. Terdiman JP, Johnson LK, Kim YS, Sleisenger MH, Gum JR, Hayes A, Weinberg VK, McQuaid KR. Chemoprevention of colonic polyps with balsalazide: an exploratory, double-blind, placebo-controlled study. Dig Dis Sci. 2009 Nov; 54(11):2488-96.
    View on PubMed
15. Terdiman JP. MYH-associated disease: attenuated adenomatous polyposis of the colon is only part of the story. Gastroenterology. 2009 Dec; 137(6):1883-6.
    View on PubMed
16. Grover S, Stoffel EM, Mercado RC, Ford BM, Kohlman WK, Shannon KM, Conrad PG, Blanco AM, Terdiman JP, Gruber SB, Chung DC, Syngal S. Colorectal cancer risk perception on the basis of genetic test results in individuals at risk for Lynch syndrome. J Clin Oncol. 2009 Aug 20; 27(24):3981-6.
    View on PubMed
17. Nguyen SP, Bent S, Chen YH, Terdiman JP. Gender as a risk factor for advanced neoplasia and colorectal cancer: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2009 Jun; 7(6):676-81.e1-3.
    View on PubMed
18. Wang JY, Terdiman JP, Vittinghoff E, Minichiello T, Varma MG. Hospitalized ulcerative colitis patients have an elevated risk of thromboembolic events. World J Gastroenterol. 2009 Feb 28; 15(8):927-35.
    View on PubMed
19. Li D, Jin C, McCulloch C, Kakar S, Berger BM, Imperiale TF, Terdiman JP. Association of large serrated polyps with synchronous advanced colorectal neoplasia. Am J Gastroenterol. 2009 Mar; 104(3):695-702.
    View on PubMed
20. Shergill AK, Terdiman JP. The early use of immunosuppression reduces morbidity in patients with moderately severe or severe Crohn's disease. Gastroenterology. 2008 Oct; 135(4):1417-20.
    View on PubMed

View on UCSF Profiles